What is the recommended dose of hydroxychloroquine (HCQ) for rheumatoid arthritis (RA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxychloroquine Dosing for Rheumatoid Arthritis

The recommended dose of hydroxychloroquine for rheumatoid arthritis is ≤5.0 mg/kg of actual body weight daily (maximum 400 mg daily), which provides a low risk of retinal toxicity while maintaining therapeutic efficacy. 1

Dosing Guidelines

Initial Dosing

  • Starting dose: 400 mg daily (can be given as a single daily dose or two divided doses) 2
  • The action of hydroxychloroquine is cumulative and may require weeks to months for maximum therapeutic effect 2

Maintenance Dosing

  • Chronic dosage: 200-400 mg daily (as a single dose or two divided doses) 2
  • Daily doses exceeding 5 mg/kg of actual body weight significantly increase the risk of retinopathy 1, 2

Risk Assessment for Retinopathy

The risk of retinal toxicity is determined by:

  1. Daily dose relative to body weight: Primary risk factor

    • ≤5.0 mg/kg/day based on actual body weight provides low risk (<2% with up to 10 years of use) 1
    • Higher doses increase risk to ~10% after 10 years 1
  2. Duration of treatment: Risk increases with longer use

    • For patients with normal screening examination, annual risk remains <5% even after 20 years of use 1
  3. Additional risk factors:

    • Renal insufficiency (HCQ is excreted in urine) 1
    • Concomitant use of tamoxifen 1
    • Pre-existing retinal or macular disease 1

Special Considerations

  • Administration: Take with food or milk to improve tolerability 2
  • Do not crush or divide tablets 2
  • Renal impairment: Patients with reduced renal function may need lower doses and closer monitoring 1
  • Monitoring: Regular ophthalmologic screening is recommended for patients on long-term therapy 1

Clinical Efficacy

  • Hydroxychloroquine is conditionally recommended over other conventional synthetic DMARDs for DMARD-naive patients with low disease activity 1
  • It can be used as monotherapy or in combination with other antirheumatic agents 2
  • Corticosteroids, salicylates, and other antirheumatic agents may be used concomitantly with hydroxychloroquine 2

Safety Considerations

  • Hydroxychloroquine is considered safe at proper doses in conjunction with appropriate eye screening 1
  • The risk of toxicity is very low for doses below 5 mg/kg of actual body weight 1
  • Cardiotoxicity, including cardiomyopathy and QT prolongation, has been reported in rare cases 2
  • Avoid use in patients with known hypersensitivity to 4-aminoquinoline compounds 2

Practical Dosing Algorithm

  1. Calculate maximum daily dose based on actual body weight:

    • Maximum dose = 5 mg/kg/day (not to exceed 400 mg daily)
    • Example: 70 kg patient → 350 mg daily maximum
  2. Typical dosing schedule:

    • Initial: 400 mg daily for 4-12 weeks to achieve therapeutic effect
    • Maintenance: Adjust to 200-400 mg daily based on response
  3. Monitor efficacy and adjust as needed:

    • If good response is achieved, continue maintenance dose
    • If inadequate response after 3-6 months, consider adding or switching to other DMARDs

Remember that hydroxychloroquine should not be avoided due to fear of retinopathy, as it is a valuable medication for RA when properly dosed and monitored.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.